Clinical and Genetic Aspects of Juvenile Onset Pompe Disease

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Johanna Holzwarth - , Justus Liebig University Giessen (Autor:in)
  • Nadja Minopoli - , Justus Liebig University Giessen (Autor:in)
  • Charlotte Pfrimmer - , Justus Liebig University Giessen (Autor:in)
  • Martin Smitka - , Klinik und Poliklinik für Kinder- und Jugendmedizin, Abteilung für Neuropädiatrie (Autor:in)
  • Sabine Borrel - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • Janbernd Kirschner - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • Nicole Muschol - , University Medical (Autor:in)
  • Hans Hartmann - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Julia B. Hennermann - , Johannes Gutenberg-Universität Mainz (Autor:in)
  • Bernd A. Neubauer - , Justus Liebig University Giessen (Autor:in)
  • Elke Hobbiebrunken - , Georg-August-Universität Göttingen (Autor:in)
  • Ralf A. Husain - , Friedrich-Schiller-Universität Jena (Autor:in)
  • Andreas Hahn - , Justus Liebig University Giessen (Autor:in)

Abstract

AbstractLittle is known about clinical symptomatology and genetics of juvenile onset Pompe disease (JOPD). The aims of this study were to analyze how these children are diagnosed, what clinical problems they have, and how phenotype is related to genotype. To accomplish this, we analyzed retrospectively data of 34 patients diagnosed after their first and before completion of their 18th birthday. Median age at diagnosis was 3.9 (range 1.1–17) years. Eight patients (23.5%) developed initial symptoms in the first year, 12 (35%) between 1 and 7 years, and 6 (18%) thereafter. Eight (23.5%) had no clinical symptoms at the time of diagnosis. Indications for diagnostics were a positive family history in three (9%), hyperCKemia in eight (23.5%), motor developmental delay in three (9%), and muscle weakness and/or pain in 17 (50%). Rare clinical signs were failure to thrive, recurrent diarrhea, and suspected hepatopathy with glycogen storage. Thirty-two different mutations were identified. Twenty-seven patients (79.5%) carried the milder c.32–13T > G mutation, known to be associated with a broad range of phenotypes. Three out of eight patients manifesting within the first year of life showed generalized muscle weakness, hypertrophic cardiomyopathy, and had to be ventilated during the course of disease, thereby demonstrating clinical overlap with infantile onset Pompe disease.These findings demonstrate that the phenotype of JOPD is broad and that the differential is not only restricted to neuromuscular disorders. Genotypic analysis was useful to delineate subjects with early onset JOPD from those with IOPD, but overall genotype–phenotype correlation was poor.

Details

OriginalspracheEnglisch
Seiten (von - bis)39-45
Seitenumfang7
FachzeitschriftNeuropediatrics
Jahrgang53
Ausgabenummer1
PublikationsstatusVeröffentlicht - 1 Feb. 2022
Peer-Review-StatusJa

Externe IDs

PubMed 34852371

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • genotype, glucosidase, phenotype, Pompe disease